Important Drug Safety Update from the MHRA on Valproate and pregnancy

24th April 2018

The MHRA have issued new guidance stating that Valproate medicines (Epilim▼, Depakote▼) are contraindicated in women and girls of childbearing potential unless a Pregnancy Prevention Programme is in place.

Read the full update here: https://www.gov.uk/drug-safety-update/valproate-medicines-epilim-depakote-contraindicated-in-women-and-girls-of-childbearing-potential-unless-conditions-of-pregnancy-prevention-programme-are-met

More News

Prescriber Ready portfolio launched

The newest portfolio to join the SCRIPT eLearning programme is now available. The Prescriber Ready portfolio aims to support non-medical healthcare professionals preparing to achieve prescriber readiness. Commissioned by NHS England, learners can access the first five...

New SCRIPT website now LIVE

We are delighted to launch our new website aimed at providing a fresh, visually appealing and intuitive user experience. This update shows our commitment to ensuring our website is modern, accessible and focused on the needs of our users. The new design includes: An...